Sebia Acquires Orgentec Diagnostika

The strategic acquisition reinforces Sebia’s global leadership in specialty diagnostics LISSES, France, June 30, 2021 /PRNewswire/ — Sebia, a leading provider of clinical protein electrophoresis equipment and reagents for diabetes and oncology detection, today announced the acquisition…

About the Author

has written 20650 stories on this site.

Copyright © 2010-2019 strategicbusinessnews.com